Screening mammography Interpreted Negative | Screening mammography Interpreted Benign
Item
1. past prior screening mammography (sm) interpreted as negative or benign (this screening must have been performed at mayo clinic rochester, minnesota).
boolean
C0203028 (UMLS CUI [1,1])
C1285553 (UMLS CUI [1,2])
C1513916 (UMLS CUI [1,3])
C0203028 (UMLS CUI [2,1])
C1285553 (UMLS CUI [2,2])
C0205183 (UMLS CUI [2,3])
Screening mammography Interpreted Heterogeneously dense | Screening mammography Interpreted Extremely dense
Item
2. past prior sm interpreted as heterogeneously dense or extremely dense (this screening must have been performed at mayo clinic rochester, minnesota).
boolean
C0203028 (UMLS CUI [1,1])
C1285553 (UMLS CUI [1,2])
C1268646 (UMLS CUI [1,3])
C0203028 (UMLS CUI [2,1])
C1285553 (UMLS CUI [2,2])
C1268647 (UMLS CUI [2,3])
Gender Mammography Lacking | Age | Gender Dense connective tissue of breast
Item
3. women younger than 50 years who had not undergone prior mammography, as most of these women have dense breasts.
boolean
C0079399 (UMLS CUI [1,1])
C0024671 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
C0001779 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C1179021 (UMLS CUI [3,2])
risk factors
Item
4. subjects had to have at least one of the following risk factors:
boolean
C0035648 (UMLS CUI [1])
BRCA1 gene mutation | BRCA2 gene mutation
Item
1. known mutation in breast cancer susceptibility gene 1 (brca1) or breast cancer susceptibility gene 2 (brca2)
boolean
C1511022 (UMLS CUI [1])
C1511024 (UMLS CUI [2])
irradiation of chest wall | irradiation of mediastinum | irradiation of axillary lymph nodes
Item
2. history of chest, mediastinal, or axillary irradiation
boolean
C2064934 (UMLS CUI [1])
C2152905 (UMLS CUI [2])
C2169036 (UMLS CUI [3])
Breast Carcinoma Personal History
Item
3. personal history of breast cancer
boolean
C0678222 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
Atypical ductal hyperplasia Biopsy | Atypical lobular hyperplasia Biopsy | Lobular carcinoma in situ Biopsy | Atypical Breast Papilloma Biopsy
Item
4. history of prior biopsy showing atypical ductal hyperplasia, atypical lobular hyperplasia, lobular carcinoma in situ, or atypical papilloma
boolean
C0442834 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C0442835 (UMLS CUI [2,1])
C0005558 (UMLS CUI [2,2])
C0334381 (UMLS CUI [3,1])
C0005558 (UMLS CUI [3,2])
C1332346 (UMLS CUI [4,1])
C0005558 (UMLS CUI [4,2])
Lifetime Risk Percentage Gail Risk Model | Lifetime Risk Percentage Claus Model
Item
5. gail or claus model lifetime risk greater than or equal to 20%
boolean
C1517878 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C1511297 (UMLS CUI [1,3])
C1517878 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C1707405 (UMLS CUI [2,3])
Risk Timespan Percentage Gail Risk Model
Item
6. gail model 5 year risk greater or equal to 2.5%
boolean
C0035647 (UMLS CUI [1,1])
C0872291 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C1511297 (UMLS CUI [1,4])
Risk Timespan Percentage Gail Risk Model
Item
7. gail model 5 year risk greater or equal to 1.6%
boolean
C0035647 (UMLS CUI [1,1])
C0872291 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C1511297 (UMLS CUI [1,4])
Breast Carcinoma First Degree Relative Quantity
Item
8. one first-degree relative with history of breast cancer
boolean
C0678222 (UMLS CUI [1,1])
C1517194 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Breast Carcinoma Second Degree Relative Quantity
Item
9. two second-degree relatives with history of breast cancer
boolean
C0678222 (UMLS CUI [1,1])
C1519210 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Informed Consent Unable
Item
1. they are unable to understand and sign the consent form
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
2. they are pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Able to sit up Quiet Duration
Item
3. they are physically unable to sit upright and still for 40 minutes.
boolean
C0560835 (UMLS CUI [1,1])
C0439654 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
Breast Carcinoma Sign or Symptom | Palpable mass | Bloody nipple discharge | Mass of axilla
Item
4. they have self-reported signs or symptoms of breast cancer (palpable mass, bloody nipple discharge, axillary mass etc.).
boolean
C0678222 (UMLS CUI [1,1])
C3540840 (UMLS CUI [1,2])
C0746412 (UMLS CUI [2])
C0541951 (UMLS CUI [3])
C0238729 (UMLS CUI [4])
Needle biopsy | Operation on breast
Item
5. they have had needle biopsy within 3 months, or breast surgery within 1 year prior to the study.
boolean
C0005560 (UMLS CUI [1])
C3714726 (UMLS CUI [2])
Adjuvant therapy | Chemoprevention | Tamoxifen | Evista | Raloxifene | Aromatase Inhibitors
Item
6. they are currently taking tamoxifen, evista (raloxifene), or an aromatase inhibitor for adjuvant therapy or chemoprevention.
boolean
C0677850 (UMLS CUI [1])
C0282515 (UMLS CUI [2])
C0039286 (UMLS CUI [3])
C0720318 (UMLS CUI [4])
C0244404 (UMLS CUI [5])
C0593802 (UMLS CUI [6])